Rani Therapeutics to Participate in September Investor Conferences

Rhea-AI Summary

Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company focusing on oral delivery of biologics and drugs, has announced its participation in two major investor conferences in September 2024. The company will be present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10 and the 2024 Cantor Global Healthcare Conference on September 18, both in New York City.

CEO Talat Imran will represent Rani at both events, delivering a company presentation at the H.C. Wainwright conference and participating in a fireside chat at the Cantor conference. Both events will also include one-on-one investor meetings. Interested parties can access live webcasts of these presentations through the 'Events' section of Rani Therapeutics' website, with replays available after the events conclude.

SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in September 2024. These conferences include:

H.C. Wainwright 26^th Annual Global Investment Conference
Location: Lotte New York Palace Hotel, New York, NY
Date: Tuesday, September 10, 2024 at 4:30 pm E.T.
Format: Company Presentation and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran

2024 Cantor Global Healthcare Conference
Location: InterContinental Barclay Hotel, New York, NY
Date: Wednesday, September 18, 2024 at 11:30am E.T.
Format: Fireside Chat and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran

Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website. The webcast replays will be available after the conclusion of the respective presentations.

About Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill^® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill^® capsule technology. For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com

Media Contact:

media@ranitherapeutics.com

FAQ

What investor conferences will Rani Therapeutics (RANI) attend in September 2024?

Rani Therapeutics (RANI) will attend the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, and the 2024 Cantor Global Healthcare Conference on September 18, 2024, both in New York City.

Who will represent Rani Therapeutics (RANI) at the September 2024 investor conferences?

Talat Imran, the Chief Executive Officer of Rani Therapeutics, will represent the company at both September 2024 investor conferences.

What type of presentations will Rani Therapeutics (RANI) give at the September 2024 conferences?

Rani Therapeutics will give a company presentation at the H.C. Wainwright conference on September 10, 2024, and participate in a fireside chat at the Cantor Global Healthcare Conference on September 18, 2024.

How can investors access Rani Therapeutics' (RANI) presentations at the September 2024 conferences?

Investors can access live webcasts of Rani Therapeutics' presentations by visiting the 'Events' section of the company's website. Webcast replays will be available after the conclusion of the presentations.